drugset / Trial / NCT02296645

Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)

NCT02296645

Phase 2 Completed 36 enrolled Zurex Pharma, Inc.
RandomizedParallel-groupDouble-blind

Summary

This is a randomized, paired-comparisons design where each subject receives two of the planned treatments.

Timeline

Start
2014-11
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chlorhexidine Small molecule 2 % Topical
Comparator Chlorhexidine Small molecule 70 % Topical
Subject ZuraPrep Unknown 70 % Topical

Indications

No indication recorded.